Indivior Pharmaceuticals Inc.

Contributing Author

Recent Articles by Indivior Pharmaceuticals Inc.

3 hours	New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder INDV GlobeNewswire
Feb-26	Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results INDV GlobeNewswire
Feb-24	Indivior to Participate in Upcoming Investor Conferences INDV GlobeNewswire
Jan-28	Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26ᵗʰ INDV GlobeNewswire
Jan-26	Indivior Announces Completion of Redomiciliation to the United States INDV GlobeNewswire